Qian, Christina
Klimchak, Alexa C.
Szabo, Shelagh M. http://orcid.org/0000-0002-9044-3192
Popoff, Evan
Iannaccone, Susan T.
Gooch, Katherine L.
Funding for this research was provided by:
Sarepta Therapeutics
Article History
Received: 8 February 2024
Accepted: 3 April 2024
First Online: 2 May 2024
Declarations
:
: Christina Qian and Shelagh M Szabo are employees, and Evan Popoff was an employee, of Broadstreet HEOR, which received funds from Sarepta Therapeutics Inc for this work. Alexa C Klimchak and Katherine L Gooch are employees of Sarepta Therapeutics Inc. and may hold stock/options. Susan T Iannaccone has received research funding or consulting fees from Avexis, Biogen, Fibrogen, Mallinckrodt, Regeneron, Sarepta, Scholar Rock, PTC Therapeutics, Pfizer, MDA, CureSMA, NIH, Genentech-Roche, and BCBS.
: Data were provided by Merative™, for access to a cut of data from the MarketScan<sup>®</sup> Multi-State Medicaid databases. Data are de-identified and are compliant with the Health Insurance Portability and Accountability Act (HIPAA) regulations; thus, institutional review board approval was not required to conduct this study.